These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 4404957)

  • 41. "Unmasking" of human lymphoid cell heteroantigens by neuraminidase treatment.
    Rosenberg SA; Plocinik BA; Rogentine GN
    J Natl Cancer Inst; 1972 May; 48(5):1271-6. PubMed ID: 4624148
    [No Abstract]   [Full Text] [Related]  

  • 42. Comparative studies on the rates of re-expression of human histocompatibility antigens after papain treatment.
    Bright S
    Tissue Antigens; 1974; 4(4):306-12. PubMed ID: 4412531
    [No Abstract]   [Full Text] [Related]  

  • 43. Antibody-induced redistribution of HL-A antigens at the cell surface.
    Kourilsky FM; Silvestre D; Neauport-Sautes C; Loosfelt Y; Dausset J
    Eur J Immunol; 1972 Jun; 2(3):249-57. PubMed ID: 4569171
    [No Abstract]   [Full Text] [Related]  

  • 44. Escape from sensitization of normal and leukemic lymphocytes.
    Grecek DR; Braun WE
    Transplantation; 1974 Aug; 18(2):187-90. PubMed ID: 4546497
    [No Abstract]   [Full Text] [Related]  

  • 45. The role of complement in the HL-A antibody-mediated lysis of lymphocytes.
    Ferrone S; Cooper NR; Pellegrino MA; Reisfeld RA
    Transplant Proc; 1974 Mar; 6(1):13-9. PubMed ID: 4856285
    [No Abstract]   [Full Text] [Related]  

  • 46. Association of HL-A antigens and beta 2-microglobulin: concepts and questions.
    Poulik MD; Ferrone S; Pellegrino MA; Sevier DE; Oh SK; Reisfeld RA
    Transplant Rev; 1974; 21(0):106-25. PubMed ID: 4139784
    [No Abstract]   [Full Text] [Related]  

  • 47. Effect of inhibitors of macromolecular synthesis on HL-A antibody mediated lysis of cultured lymphoblasts.
    Ferrone S; Pellegrino MA; Dierich MP; Reisfeld RA
    Tissue Antigens; 1974; 4(4):275-82. PubMed ID: 4528542
    [No Abstract]   [Full Text] [Related]  

  • 48. [The differentiation of the effect of anti-human IgM on lymphocytes in vitro].
    Schwenke H; von Baehr R; Storch H
    Allerg Immunol (Leipz); 1973; 19(2-4):226-32. PubMed ID: 4281627
    [No Abstract]   [Full Text] [Related]  

  • 49. [Microlymphocytotoxicity test with anti-IgG antiglobulin and cross reactivity of HL-A antigens].
    Delmas-Marsalet Y; Woodbury M; Corley R; Amos DB
    Nouv Rev Fr Hematol; 1974; 14(3):409-16. PubMed ID: 4277879
    [No Abstract]   [Full Text] [Related]  

  • 50. Independence of HL-A antigens and immunoglobulin determinants on the surface of human lymphoid cells.
    Preud'homme JL; Neauport-Sautes C; Piat S; Silvestre D; Kourilsky FM
    Eur J Immunol; 1972 Jun; 2(3):297-300. PubMed ID: 4119937
    [No Abstract]   [Full Text] [Related]  

  • 51. Human leukemia antigens: partial isolation and characterization.
    Metzgar RS; Mohanakumar T; Green RW; Miller DS; Bolognesi DP
    J Natl Cancer Inst; 1974 May; 52(5):1445-53. PubMed ID: 4208712
    [No Abstract]   [Full Text] [Related]  

  • 52. Phenotypic suppression of H-2 antigens and topography of the cell surface.
    Lengerová A; Pokorná Z; Viklický V; Zelený V
    Tissue Antigens; 1972; 2(4):332-40. PubMed ID: 4586482
    [No Abstract]   [Full Text] [Related]  

  • 53. The preparation and purification of HL-A monospecific antigens using platelets and various lymphoid sources.
    Voigtmann R; Uhlenbruck G; Pardoe GI; Rogers K
    Eur J Immunol; 1974 Oct; 4(10):674-8. PubMed ID: 4139020
    [No Abstract]   [Full Text] [Related]  

  • 54. The utilization of antiglobulin reagents in cytotoxicity testing for HL-A.
    dos Reis AP; Betuel H; Reisner EG; Amos DB
    Transplantation; 1973 Jan; 15(1):36-41. PubMed ID: 4123048
    [No Abstract]   [Full Text] [Related]  

  • 55. Neuraminidase reversal of resistance to lysis of herpes simplex virus-infected cells by antibody and complement.
    Tompkins WA; Seth P; Gee S; Rawls WE
    J Immunol; 1976 Feb; 116(2):489-95. PubMed ID: 175118
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Lymphocytes HLA antigens expressivity after neuraminidase treatment (author's transl)].
    de Mouzon A; Ohayon E; Oksman-Domejean F; Ducos J
    Ann Immunol (Paris); 1976; 127(5):687-701. PubMed ID: 984732
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Surface immunoglobulin on H-2-activated T lymphocytes.
    Sprent J; Hudson L
    Transplant Proc; 1973 Dec; 5(4):1731-3. PubMed ID: 4544163
    [No Abstract]   [Full Text] [Related]  

  • 58. Detection of HL-A and other cell-surface antigens on cultured cells by a cytotoxic plating inhibition test.
    Takasugi M; Terasaki PI
    J Natl Cancer Inst; 1972 Nov; 49(5):1229-37. PubMed ID: 4675381
    [No Abstract]   [Full Text] [Related]  

  • 59. Defective activation of b5 bearing lymphocytes in rabbits recovering from b5 allotype suppression.
    Harrison MR; Elfenbein GJ; Mage RG
    Cell Immunol; 1974 Mar; 11(1-3):231-8. PubMed ID: 4455393
    [No Abstract]   [Full Text] [Related]  

  • 60. The formation of stable E rosettes after neuraminidase treatment of either human peripheral blood lymphocytes or of sheep red blood cells.
    Galili U; Schlesinger M
    J Immunol; 1974 May; 112(5):1628-34. PubMed ID: 4818458
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.